Cedar was founded in 2016 by Arel Lidow, Florian Otto, and Kareem Zaki. While the company is growing quickly, nobody has publicly discussed plans for a future IPO. These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.

Cedar is a fintech company and developer of a healthcare financial engagement platform for hospitals, health systems and medical groups that clarifies and simplifies the financial experience for patients, improving bill resolution and payment outcomes for providers. In 2021, Cedar acquired OODA Health, the makers of a powerful billing platform, for $425 million. Cedar has raised a total of $350 million in venture capital funding, most recently in a $200 million round that included investors Tiger Global Management, Thrive Capital, Concord Health Partners, and Andreessen Horowitz. This latest round raised the company's valuation to $3.2 billion.

Register for Details

For more details on financing and valuation for Cedar, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Cedar

To invest in Cedar pre-IPO

Can you invest in Cedar pre-IPO?

Cedar is a privately held company and is not publicly traded, therefore investing in Cedar pre-IPO is only available to accredited investors. If you meet the accreditation criteria, you can learn more about Forge’s Secondary Marketplace and how to invest in private companies before their potential IPO. If you are not accredited, find out how to begin the process and qualify for new investment opportunities.

Can you sell shares of Cedar before it goes public?

You can seek to sell your shares in Cedar while it remains private. If you are considering selling, you can register today for free to get started. Once registered, a Private Market Specialist will guide you through any questions you might have. You may also continue to browse through our resources to help you understand the implications and procedures involved in selling your private market shares.

What is the pre-IPO value of my Cedar shares?

To determine the value of your Cedar shares, create a free account to gain access to Forge’s platform. In addition to the Forge Price, Forge Markets contains pricing information for hundreds of pre-IPO companies such as Last Closed Trade Price. A Private Market Specialist will also be available to assist you with any inquiries related to your Cedar shares. You can also learn more about how to sell your private shares before getting started.

Is Cedar a publicly traded company?

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

To learn more about Cedar potential IPO

Will Cedar go IPO?

Cedar has not yet filed for an IPO. However, it’s important to note that IPOs are not the sole avenue for a private company to transition to public trading. Private companies can also go public through alternative methods such as but limited to Special Purpose Acquisition Companies (SPACs), direct listings, or mergers and acquisitions. Find out which companies are eyeing an IPO on our Tech IPO Calendar 2024.

What is Cedar’s IPO price?

The Cedar IPO price does not exist at this time, as Cedar is still a private company and has not yet conducted an IPO. To explore secondary market data and access private market pricing details and data that may be related to Cedar register for Forge Markets, today.

When was Cedar founded?

Cedar was founded in 2016.

What is Cedar funding to date?

Cedar has raised $389.1MM to date.

Who are Cedar’s major investors?

Tiger Global Management
Andreessen Horowitz
Craft Ventures
Founders Fund
Kaiser Permanente Ventures
Lakestar
Alkeon Capital Management
Crew Capital

Cedar Funding Rounds and Valuation

Funding History Chart
Funding Round Details
Funding Date Share Class Amount Raised Price per Share Post-Money Valuation Key Investors
12/19/2022 Series D $255MM $xx.xx $3.19B Tiger Global Management, Andreessen Horowitz, Thrive Capital, Concord Health Partners, Memorial Hermann Health System
Price per Share
$xx.xx
Shares Outstanding
1,060,175
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Tiger Global Management, Andreessen Horowitz, Thrive Capital, Concord Health Partners, Memorial Hermann Health System
06/22/2020 Series C $79.8MM $xx.xx $814.72MM Andreessen Horowitz, JP Morgan
Price per Share
$xx.xx
Shares Outstanding
1,335,516
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Andreessen Horowitz, JP Morgan
06/25/2018 Series B $41.3MM $xx.xx $286.28MM Kinnevik, Founders Fund, Thrive Capital, Lakestar, Sound Ventures, Kevin Systrom, Nat Turner
Price per Share
$xx.xx
Shares Outstanding
1,978,507
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Kinnevik, Founders Fund, Thrive Capital, Lakestar, Sound Ventures, Kevin Systrom, Nat Turner
12/06/2017 Series A-1 $3MM $xx.xx $73.6MM Founders Fund, Martin Ventures, SV Angel, Thrive Capital
Price per Share
$xx.xx
Shares Outstanding
1,288,214
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Founders Fund, Martin Ventures, SV Angel, Thrive Capital
12/06/2017 Series A $10MM $xx.xx $73.6MM Founders Fund, Martin Ventures, SV Angel, Thrive Capital
Price per Share
$xx.xx
Shares Outstanding
1,533,567
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Founders Fund, Martin Ventures, SV Angel, Thrive Capital
Updated on: Nov 17, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.